Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Echinococcus granulosus antigen 5: a novel immunomodulator that targets NF-κB signaling to suppress inflammation in THP-1 monocyte.

Created on 19 Sep 2026

Authors

Fan Zhang, Zhi Li, Jianlin Xu, Hong Duo, Xueyong Zhang, Mengtong Lei, Dan Jia, Xiuying Shen, Ru Meng, Yong Fu

Published in

International immunopharmacology. Pages 117384. Sep 18, 2026. Epub Sep 18, 2026.

Abstract

Chronic infection by Echinococcus granulosus leads to the establishment of fluid-filled cysts (hydatid cysts) in the liver or lungs of infected hosts, which can escape destruction by the host immune system for long periods. Ag5 is abundantly expressed in the cyst fluid of the fine-grained E. granulosus and plays an important role in immune tolerance in cystic echinococcosis. However, the role that Ag5 plays in monocytes is not fully known. Here, the expression characteristics and function of Ag5 were explored in human monocytic THP-1 cells by various assays. The findings of the present study revealed that Ag5 inhibited the polarization of THP-1 cells into macrophages and reduced the expression profiles of intracellular pro-inflammatory factors such as TNF-α, IL-1β, and IL-6 through the NF-κB pathway. These findings suggest that Ag5 plays a crucial role in E. granulosus's ability to suppress host immune responses and support the long-term survival of the parasite.

PMID:
42760161
Bibliographic data and abstract were imported from PubMed on 19 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement